Earnings Call for Q2FY21 of Natco Pharma

Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer

893.7000 31.40 (3.64%)

NSE May 29, 2025 15:31 PM

45.47% Fall from 52W High

Volume: 4.0M

High volume today

Conference/Earnings Calls Alerts

Natco Pharma Ltd.

13 Nov 2020

893.70

3.64%

Earnings Call for Q2FY21 of Natco Pharma

Conference Call with Natco Pharma Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.

More from Natco Pharma Ltd.

Recommended

Market closes higher, Alkem Labs' Q4 net profit rises 4.2% YoY to Rs 305.9 crore

Trendlyne Marketwatch | 29 May 2025, 04:09PM

Nifty 50’s annual winners: Top-performing stocks of the past decade

The Baseline | 29 May 2025, 01:00PM

Earnings Call Transcript - Q4FY20 for Natco Pharma